Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Blood Cancer Discovery|April 15, 2025
Beyond Trial and Error: A Mathematical Model Wrangles DLBCL Heterogeneity Toward Optimizing Combination TherapyJordan S Goldstein, Nick A Phillips, Ash A Alizadeh
Case Reports in Gastrointestinal Medicine|July 30, 2019
Nonfatal Hyperammonemic Encephalopathy as a Late Complication of Roux-en-Y Gastric BypassJuan D Salcedo, Jordan S Goldstein, Jose M Quinonez, et al.
Leukemia & Lymphoma|January 12, 2019
Rural and urban patients with diffuse large B-cell and follicular lymphoma experience reduced overall survival: a National Cancer DataBase studyAndrew J Ritter, Jordan S Goldstein, Amy A Ayers, et al.
Cancer|February 2, 2019
A population-based multistate model for diffuse large B-cell lymphoma-specific mortality in older patientsÇağlar Çağlayan, Jordan S Goldstein, Turgay Ayer, et al.
Seminars in Hematology|April 15, 2026
Roadmap for developing MRD as an early endpoint for drug approval in lymphomaJordan S Goldstein, Steven X Wang, Martine E D Chamuleau, et al.
Leukemia & Lymphoma|July 6, 2019
Insurance status impacts overall survival in Burkitt lymphomaJordan S Goldstein, Jeffrey M Switchenko, Madhusmita Behera, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 29, 2019
Assessing the Effectiveness of Treatment Sequences for Older Patients With High-risk Follicular Lymphoma With a Multistate ModelÇağlar Çağlayan, Hiromi Terawaki, Turgay Ayer, et al.
Blood|July 26, 2018
Disparities in survival by insurance status in follicular lymphomaJordan S Goldstein, Loretta J Nastoupil, Xuesong Han, et al.
JCO Clinical Cancer Informatics|January 15, 2019
Informatics Approaches to Address New Challenges in the Classification of Lymphoid MalignanciesJacob Jordan, Jordan S Goldstein, David L Jaye, et al.
Expert Review of Hematology|September 13, 2019
Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphomaR Andrew Harkins, Andres Chang, Sharvil P Patel, et al.
Pageof 2